The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...

The Centers for Medicare and Medicaid Services said late Friday that it would not cover medications such as Wegovy that are ...

The Centers for Medicare and Medicaid Services said it would not cover the medications under Medicare’s Part D coverage.

The CMS has opted not to move forward with a plan that would have extended Medicare coverage to obesity drugs for millions of ...

Sen. John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access ...

The Trump administration on Friday scrapped a Biden administration proposal to have Medicare cover anti-obesity drugs, ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump officials reject Medicare coverage ...

CMS ends Biden-era proposal to expand Medicare coverage of anti-obesity drugs. Seniors continue paying out of pocket for ...

Health and Human Services Secretary Robert F. Kennedy Jr. has been critical of the drugs, instead placing a focus on ...

The Centers for Medicare & Medicaid Services (CMS) finalized a Medicare Advantage (MA) rule proposed by the Biden ...

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...

The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...